Advanced Medical Stopcock Market Technological Advancements, Demand and Future Industry Trends 2028

The Advanced Medical Stopcock Market is expected to grow from US$ 941.95 million in 2022 to US$ 1,230.60 million by 2028; it is estimated to grow at a CAGR of 4.6% from 2022 to 2028.

The rising number of surgical procedures is fueling the overall advanced medical stopcock market growth.

Medical stopcock are used with infusion pumps to administer medications through the catheter to a specific part of the body during or after surgical procedures. Infusion therapy is used when other methods are less effective or when the patient needs medication for the long term. Stopcock are used after surgeries to provide medicines in fluid forms when the patient is under observation.

Get Exclusive Sample PDF @: https://www.premiummarketinsights.com/sample/TIP00007263?utm_source=OpenPr&utm_medium=10640

Analysis of the Top Market Players:

1. B. Braun SE
2. Smiths Medical Inc
3. Nipro Corp
4. Elcam Medical Group Co
5. Merit Medical Systems Inc
6. CODAN US Corp
7. Nordson Corp
8. Cook Medical LLC
9. JCM MED SaRL
10. Utah Medical Products Inc.

In this report, the market has been segmented on the basis of:

Type (Low-Pressure Stopcock, Medium-Pressure Stopcock, and High-Pressure Stopcock)
End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Homecare)

Access full Report Description, TOC, Table of Figure, Chart, etc. @: https://www.premiummarketinsights.com/reports-tip/advanced-medical-stopcock-market

The number of surgical procedures such as cesarean sections is growing globally. According to the latest research by the World Healthcare Organization (WHO), in 2021, the preference for cesarean section continues to rise globally, accounting for more than 21% of all childbirths. It is expected to increase over the coming decade, with approximately 29% of all births to occur by cesarean section by 2030. Moreover, as per American Heart Association, Heart Disease & Stroke Statistical Update Fact Sheet 2022 (Global Burden of Disease), in 2020, approximately 19.1 million deaths were caused due to cardiovascular disease (CVD). The age-adjusted death rate per 100,000 population was 239.8.

Further, the age-adjusted prevalence rate was 7,354.1 per 100,000. Thus, the rising CVD patient population is increasing the number of angiography or angioplasty procedures. These procedures require high-pressure stopcock; as a result, the demand for advanced medical stopcock is increasing. Thus, the surge in surgical procedures is driving the global advanced medical stopcock market.

Order a copy of this research report at @: https://www.premiummarketinsights.com/buy/TIP00007263?utm_source=OpenPr&utm_medium=10640

Contact Us:
If you have any queries about this report or if you would like further information, please
Contact Person: Ankit Mathur
Phone: +1-646-491-9876
Email: sales@premiummarketinsights.com

About Us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost-effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
Premium Market Insights has an extensive coverage of industry reports, company reports and country reports across all industries. In case your research needs are not met by syndicated reports offered by leading publishers, we can help you by offering a customized research solution by liaising with different research agencies saving your valuable time and money.
We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.

This release was published on openPR.